Arcutis Biotherapeutics, Inc. (ARQT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 105.4M | 129.5M | 99.22M | 81.5M | 65.85M | 71.36M | 44.76M | 30.86M | 49.57M | 13.53M | 38.11M | 5.19M |
| Revenue Growth % | 60.07% | 81.48% | 121.69% | 164.13% | 32.84% | 427.58% | 17.44% | 494.57% | 1682.42% | 356.81% | 5156.41% | - |
| Cost of Goods Sold | 9.78M | 11.69M | 8.69M | 7.49M | 8.83M | 6.91M | 5.5M | 3.46M | 3.26M | 2.25M | 1.18M | 776K |
| COGS % of Revenue | 9.28% | 9.03% | 8.75% | 9.19% | 13.41% | 9.68% | 12.3% | 11.23% | 6.57% | 16.61% | 3.1% | 14.95% |
| Gross Profit | 95.61M | 117.81M | 90.53M | 74.01M | 57.02M | 64.45M | 39.25M | 27.39M | 46.31M | 11.28M | 36.93M | 4.41M |
| Gross Margin % | 90.72% | 90.97% | 91.25% | 90.81% | 86.59% | 90.32% | 87.7% | 88.77% | 93.43% | 83.39% | 96.9% | 85.05% |
| Gross Profit Growth % | 67.7% | 82.79% | 130.65% | 170.18% | 23.11% | 471.41% | 6.3% | 520.62% | 2217.97% | 355.57% | 7998.03% | 1986.32% |
| Operating Expenses | 104.7M | 99.43M | 82.01M | 88.62M | 81.55M | 72.09M | 78.32M | 77.47M | 77.94M | 72.45M | 73.83M | 71.18M |
| OpEx % of Revenue | 99.34% | 76.78% | 82.65% | 108.73% | 123.84% | 101.02% | 174.99% | 251.06% | 157.23% | 535.63% | 193.74% | 1371.43% |
| Selling, General & Admin | 74.08M | 78.98M | 62.4M | 69.17M | 64M | 57.61M | 58.82M | 58.17M | 54.79M | 48.67M | 47.59M | 45.96M |
| SG&A % of Revenue | 70.28% | 60.98% | 62.9% | 84.87% | 97.2% | 80.73% | 131.42% | 188.52% | 110.54% | 359.86% | 124.89% | 885.51% |
| Research & Development | 30.63M | 20.45M | 19.6M | 19.45M | 17.54M | 14.48M | 19.5M | 19.3M | 23.14M | 23.77M | 26.24M | 25.22M |
| R&D % of Revenue | 29.06% | 15.79% | 19.76% | 23.87% | 26.64% | 20.29% | 43.57% | 62.54% | 46.68% | 175.77% | 68.84% | 485.92% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.09M | 18.39M | 8.53M | -14.61M | -24.53M | -7.63M | -39.07M | -50.08M | -31.62M | -61.17M | -36.9M | -66.76M |
| Operating Margin % | -8.62% | 14.2% | 8.59% | -17.93% | -37.25% | -10.7% | -87.29% | -162.28% | -63.79% | -452.23% | -96.84% | -1286.38% |
| Operating Income Growth % | 62.95% | 340.92% | 121.82% | 70.82% | 22.43% | 87.52% | -5.86% | 24.99% | 58.54% | 10.6% | 64.77% | -1.42% |
| EBITDA | -9.09M | 19.65M | 9.09M | -14.05M | -21.4M | -7.17M | -37.63M | -49.73M | -31.26M | -60.78M | -36.52M | -66.29M |
| EBITDA Margin % | -8.62% | 15.17% | 9.16% | -17.24% | -32.5% | -10.05% | -84.09% | -161.14% | -63.07% | -449.39% | -95.82% | -1277.24% |
| EBITDA Growth % | 57.52% | 373.91% | 124.15% | 71.75% | 31.56% | 88.2% | -3.06% | 24.99% | 58.81% | 10.71% | 65.06% | -1.06% |
| D&A (Non-Cash Add-back) | 0 | 1.26M | 562K | 563K | 3.13M | 458K | 1.43M | 351K | 358K | 385K | 387K | 474K |
| EBIT | -9.09M | 20.87M | 10.56M | -12.52M | -21.8M | -4.91M | -34.88M | -44.85M | -27.58M | -58.5M | -34.18M | -63.64M |
| Net Interest Income | 0 | -3M | -3.07M | -3.03M | -2.98M | -5.55M | -6.65M | -7.48M | -7.48M | -7.76M | -7.56M | -7.35M |
| Interest Income | 2.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -4.37M | 3M | 3.07M | 3.03M | 2.98M | 5.55M | 6.65M | 7.48M | 7.48M | 7.76M | 7.56M | 7.35M |
| Other Income/Expense | -2.11M | -522K | -1.04M | -933K | -252K | -2.83M | -2.47M | -2.25M | -3.44M | -5.09M | -4.84M | -4.23M |
| Pretax Income | -11.2M | 17.86M | 7.49M | -15.54M | -24.78M | -10.46M | -41.54M | -52.33M | -35.06M | -66.26M | -41.74M | -70.99M |
| Pretax Margin % | -10.63% | 13.79% | 7.55% | -19.07% | -37.63% | -14.67% | -92.81% | -169.59% | -70.73% | -489.86% | -109.53% | -1367.84% |
| Income Tax | 93K | 470K | 80K | 342K | 279K | 323K | 0 | 0 | 324K | 25K | 3.02M | 0 |
| Effective Tax Rate % | -0.83% | 2.63% | 1.07% | -2.2% | -1.13% | -3.09% | 0% | 0% | -0.92% | -0.04% | -7.24% | 0% |
| Net Income | -11.29M | 17.39M | 7.41M | -15.89M | -25.06M | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M | -44.77M | -70.99M |
| Net Margin % | -10.72% | 13.43% | 7.47% | -19.49% | -38.06% | -15.12% | -92.81% | -169.59% | -71.38% | -490.05% | -117.47% | -1367.84% |
| Net Income Growth % | 54.93% | 261.24% | 117.84% | 69.64% | 29.17% | 83.72% | 7.21% | 26.28% | 55.63% | 7.96% | 58.44% | -5.32% |
| Net Income (Continuing) | -11.29M | 17.39M | 7.41M | -15.89M | -25.06M | -10.79M | -41.54M | -52.33M | -35.38M | -66.28M | -44.77M | -70.99M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.09 | 0.13 | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 |
| EPS Growth % | 55% | 245.74% | 116.91% | 69.05% | 37.5% | 87.61% | 54.79% | 63.79% | 75.38% | 41.94% | 62.37% | 13.43% |
| EPS (Basic) | -0.09 | 0.14 | 0.06 | -0.13 | -0.20 | -0.09 | -0.33 | -0.42 | -0.32 | -0.72 | -0.73 | -1.16 |
| Diluted Shares Outstanding | 129.37M | 135.63M | 132.88M | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M |
| Basic Shares Outstanding | 129.37M | 128.25M | 127.62M | 127M | 126.04M | 120.96M | 124.3M | 123.48M | 111.05M | 92.58M | 61.73M | 61.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |